These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11850204)

  • 1. Aromatase overexpression transgenic mice model: cell type specific expression and use of letrozole to abrogate mammary hyperplasia without affecting normal physiology.
    Mandava U; Kirma N; Tekmal RR
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):27-34. PubMed ID: 11850204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of letrozole as a chemopreventive agent in aromatase overexpressing transgenic mice.
    Luthra R; Kirma N; Jones J; Tekmal RR
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):461-7. PubMed ID: 14623545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands.
    Tekmal RR; Kirma N; Gill K; Fowler K
    Endocr Relat Cancer; 1999 Jun; 6(2):307-14. PubMed ID: 10731124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice.
    Kirma N; Gill K; Mandava U; Tekmal RR
    Cancer Res; 2001 Mar; 61(5):1910-8. PubMed ID: 11280746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase and COX-2 expression in human breast cancers.
    Brodie AM; Lu Q; Long BJ; Fulton A; Chen T; Macpherson N; DeJong PC; Blankenstein MA; Nortier JW; Slee PH; van de Ven J; van Gorp JM; Elbers JR; Schipper ME; Blijham GH; Thijssen JH
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):41-7. PubMed ID: 11850206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of aromatase in transgenic male mice results in the induction of gynecomastia and other biochemical changes in mammary glands.
    Gill K; Kirma N; Tekmal RR
    J Steroid Biochem Mol Biol; 2001 Apr; 77(1):13-8. PubMed ID: 11358670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance.
    Dabydeen SA; Kang K; Díaz-Cruz ES; Alamri A; Axelrod ML; Bouker KB; Al-Kharboosh R; Clarke R; Hennighausen L; Furth PA
    Carcinogenesis; 2015 Jan; 36(1):122-32. PubMed ID: 25421723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities.
    Tekmal RR; Ramachandra N; Gubba S; Durgam VR; Mantione J; Toda K; Shizuta Y; Dillehay DL
    Cancer Res; 1996 Jul; 56(14):3180-5. PubMed ID: 8764102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammary gland development in transgenic male mice expressing human P450 aromatase.
    Li X; Wärri A; Mäkelä S; Ahonen T; Streng T; Santti R; Poutanen M
    Endocrinology; 2002 Oct; 143(10):4074-83. PubMed ID: 12239119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue.
    Fang Z; Yang S; Gurates B; Tamura M; Simpson E; Evans D; Bulun SE
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3460-6. PubMed ID: 12107266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice.
    Tekmal RR; Liu YG; Nair HB; Jones J; Perla RP; Lubahn DB; Korach KS; Kirma N
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):9-15. PubMed ID: 15955696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intratumoral aromatase model: studies with aromatase inhibitors and antiestrogens.
    Brodie AH; Jelovac D; Long B
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):283-8. PubMed ID: 14623522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple structural and functional abnormalities in the p450 aromatase expressing transgenic male mice are ameliorated by a p450 aromatase inhibitor.
    Li X; Strauss L; Mäkelä S; Streng T; Huhtaniemi I; Santti R; Poutanen M
    Am J Pathol; 2004 Mar; 164(3):1039-48. PubMed ID: 14982857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic observations in MCF-7 aromatase xenografts.
    Brodie A; Jelovac D; Macedo L; Sabnis G; Tilghman S; Goloubeva O
    Clin Cancer Res; 2005 Jan; 11(2 Pt 2):884s-8s. PubMed ID: 15701882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity.
    Long BJ; Tilghman SL; Yue W; Thiantanawat A; Grigoryev DN; Brodie AM
    J Steroid Biochem Mol Biol; 1998 Nov; 67(4):293-304. PubMed ID: 9883986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of letrozole on estradiol production and P450 aromatase messenger RNA expression of cultured luteinized granulosa cells from women with and without endometriosis.
    Lu X; Wu Y; Gao XH; Wang YW; Wang L; Sun XX
    Fertil Steril; 2012 Jul; 98(1):131-5. PubMed ID: 22578533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A humanized pattern of aromatase expression is associated with mammary hyperplasia in mice.
    Zhao H; Pearson EK; Brooks DC; Coon JS; Chen D; Demura M; Zhang M; Clevenger CV; Xu X; Veenstra TD; Chatterton RT; DeMayo FJ; Bulun SE
    Endocrinology; 2012 Jun; 153(6):2701-13. PubMed ID: 22508516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of P450 aromatase enhances gonadotropin secretion in early and midpubertal boys: evidence for a pituitary site of action of endogenous E.
    Wickman S; Dunkel L
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4887-94. PubMed ID: 11600558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of aromatase overexpression on mammary growth and gene expression in the aromatase x transforming growth factor alpha double transgenic mice.
    Kirma N; Mandava U; Wuichet K; Tekmal RR
    J Steroid Biochem Mol Biol; 2001 Nov; 78(5):419-26. PubMed ID: 11738552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.